Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Lai, 2020, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2020.105924

Wang, 2020, A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence”, Int J Antimicrob Agents

WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. [https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020]

Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, JAMA, 10.1001/jama.2020.2648

Santé Publique France. Infection au nouveau Coronavirus (SARS-CoV-2), COVID-19, France et Monde [https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/articles/infection-au-nouveau-coronavirus-sars-cov-2-covid-19-france-et-monde]

Colson, 2020, Chloroquine for the 2019 novel coronavirus SARS-CoV-2, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2020.105923

Colson, 2020, Chloroquine and hydroxychloroquine as available weapons to fight COVID-19, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2020.105932

Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res, 10

Gao, 2020, Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci Trends, 10.5582/bst.2020.01047

Chinese Clinical Trial Registry. http://www.chictr.org.cn/searchproj.aspx?title=%E6%B0%AF%E5%96%B9&officialname=&subjectid=&secondaryid=&applier=&studyleader=&ethicalcommitteesanction=&sponsor=&studyailment=&studyailmentcode=&studytype=0&studystage=0&studydesign=0&minstudyexecutetime=&maxstudyexecutetime=&recruitmentstatus=0&gender=0&agreetosign=&secsponsor=&regno=&regstatus=0&country=&province=&city=&institution=&institutionlevel=&measure=&intercode=&sourceofspends=&createyear=0&isuploadrf=&whetherpublic=&btngo=btn&verifycode=&page=1.

2020, Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia], Zhonghua Jie He He Hu Xi Za Zhi, 43, 185

Biot, 2006, Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities, J Med Chem, 49, 2845, 10.1021/jm0601856

Marmor, 2016, Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision), Ophthalmology, 123, 1386, 10.1016/j.ophtha.2016.01.058

Yao, 2020, In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Clin Infect Dis, 10.1093/cid/ciaa237

Raoult, 1999, Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine, Arch Intern Med, 159, 167, 10.1001/archinte.159.2.167

Lagier, 2018, Whipple's disease and Tropheryma whipplei infections: when to suspect them and how to diagnose and treat them, Curr Opin Infect Dis, 31, 463, 10.1097/QCO.0000000000000489

Amrane, 2020, Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral hospital in Marseille, France, - January 31st to March 1st, 2020: A respiratory virus snapshot, Travel Med Infect Dis, 10.1016/j.tmaid.2020.101632

Armstrong, 2017, Simultaneous UHPLC-UV analysis of hydroxychloroquine, minocycline and doxycycline from serum samples for the therapeutic drug monitoring of Q fever and Whipple's disease, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 1060, 166, 10.1016/j.jchromb.2017.06.011

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 10.1016/S0140-6736(20)30566-3

Retallack, 2016, Zika virus cell tropism in the developing human brain and inhibition by azithromycin, Proc Natl Acad Sci U S A, 113, 14408, 10.1073/pnas.1618029113

Madrid, 2015, Evaluation of Ebola Virus Inhibitors for Drug Repurposing, ACS Infect Dis, 1, 317, 10.1021/acsinfecdis.5b00030

Bosseboeuf, 2018, Azithromycin inhibits the replication of Zika virus, J Antivirals Antiretrovirals, 10, 6, 10.4172/1948-5964.1000173

Bacharier, 2015, Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: A randomized clinical trial, JAMA, 314, 2034, 10.1001/jama.2015.13896